Todd Mandell

Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid Addiction

M. Kraus, Daniel P. Alford, Margaret Kotz et al. · Journal of Addiction Medicine · 2011 · 267 citations

Medicine, Pharmacology, Pharmacotherapy +15

Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

Bradley D. Stein, Rosalie Liccardo Pacula, Adam J. Gordon et al. · Milbank Quarterly · 2015 · 99 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacotherapy +17

Diversion of Buprenorphine/Naloxone Coformulated Tablets in a Region with High Prescribing Prevalence

Andrew A. Monte, Todd Mandell, Bonnie B. Wilford et al. · Journal of Addictive Diseases · 2009 · 88 citations

Nursing, Pharmacology, Pharmacy Practice +17

Development of a Substance Abuse Program for Opioid-Dependent Nonurban Pregnant Women Improves Outcome

Marjorie Meyer, Anna Benvenuto, Diantha B. Howard et al. · Journal of Addiction Medicine · 2012 · 29 citations

Medicine, Maternal Health, Obstetrics +14

Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process

Carrie M. Farmer, Dawn Lindsay, Jessica Williams et al. · Substance Abuse · 2015 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +17